Mechanism and renal function of irbesartan hydrochlorothiazide on patients with essential hypertension
LIU Bi-keng;ZHUANG Wei;LIN Jin-xiu;Department of Pharmacy;the First Affiliated Hospital of Fujian Medical University;Department of Cardiology;the First Affiliated Hospital of Fujian Medical University;

..............page:2089-2092

Clinical study of serum expression of cysteine leukotriene in children with obstructive sleep apnea hypopnea syndrome
ZHENG Guo-jun;WU Xiao-yan;LI Yue;SHI Zheng-xian;Department of Otorhinolaryngology;Hospital of Integrated Chinese and Western Medicine Affiliated to Zhejiang Chinese Medicine University;

..............page:2093-2095

Clinical effcet of dexmedetomidine in mechanically ventilated patients in intensive care unit
TIAN Yong-gang;QIAO Lu-jun;SONG Xiu-mei;Department of Intensive Medicine;Shandong Shengli Oil-field Central Hospital;Department of Anesthesia;Thousand-Buddha Mountain Hospital;

..............page:2096-2098

Clinical research on gabapentin and stellate ganglion block in the treatment of chronic tension-type headache
CHEN Jian-jun;HUANG Yue-jin;WU Zhi-ping;HUANG Hui-fen;Department of Neurology;Lishui Central Hospital;

..............page:2099-2101

Clinical efficacy and safety of docetaxel plus cisplatin combined with concurrent radiation in the treatment of stage Ⅲ non-small cell lung cancer
KE Chun-lin;LUO Rong-gang;LIN Jian-bo;LIU Bo;LI Xu;LAI Fan-cai;Department of Thoracic Surgery;the 1st Affiliated Hospital of Fujian Medical University;

..............page:2102-2104

Study of relationship between the state of sugar metabolic regulation and serum 25-hydroxyl Vitamin D3 levels of healthy adults
LI Ming-xia;SHI Li;ZHAO Yi-feng;HAO Wei-fang;ZUO Li-juan;ZHANG Ming-hui;REN Wei-dong;GU Jun;Department of Endocrine;The First Affiliated Hospital of Hebei North University;

..............page:2105-2107

Clinical study of misoprostol for the induced labor of late pregnancy
LIU Hai-yan;CHEN Han;LI Zhi;Department of Obstetrical;Haidian Maternal and Child Health Hospital;

..............page:2108-2110+2169

Tolerance study of ulinastatin injection in Chinese healthy volunteers
LIU Yang;WANG Qian;ZHAO Hui-ying;JIANG Dao-li;WANG Yan;LI Jia-peng;WEI Zhong-na;AN You-zhong;RONG Lian-chen;XU Ling;ZHAO Li-bo;FANG Yi;Department of Pharmacy;Peking University People’s Hospital;School of Pharmaceutical Sciences;Peking University Health Centre;Critical Care Medicine;Peking University People’s Hospital;Shanghai University of Traditional Chinese Medicine Clinical Research Center;Techpool Bio-pharma Co.Ltd;

..............page:2111-2113

Effect of cytochrome P450 2D6* 10 polymorphism on the pharmacokinetics of oral nebivolol after single and multiple doses
CAI Ning-fang;LI Bi-feng;HUANG Xiao-hong;XU Ke-zhen;CAI Meng-yun;FENG Hui-ping;HE Li-hua;YU Min;GUO Xin;CHENG Ze-neng;Department of Pharmacy;Zhangzhou Municipal Hospital of Fujian Province;Department of Paediatrics;Zhangzhou Municipal Hospital of Fujian Province;Department of Biopharmaceutics;School of Pharmaceutical Sciences;Central South University;Analytical and Testing Center;Hunan Tiger Xiangya R&D Co.;Ltd;

..............page:2114-2117

Pharmacokinetic study of vorinostat in cutaneous T cell lymphoma patients
ZHENG Jing;QIN Yong-ping;MIAO Jia;ZHANG Li;LIU Wen;SHU Shi-qing;WANG Ying;ZHU Xiao-hong;PhaseⅠ Clinical Research Unit;West China Hospital;Sichuan University;

..............page:2118-2120

Expression of four kinds of miRNAs in isoniazid-induced liver injury rats
LI Yu-hong;ZHU Ling-yan;NIU Chen;WANG Yue;TIAN Shen-qian;SHI Zhe;XIAO Yong-hong;HAN Tie-sheng;FENG Fu-min;Hebei Province Key Laboratory of Occupational Health and Safety for Coal Industry;School of Public Health;North China University of Science and Technology;

..............page:2121-2124

Effect of down regulation of EZH2 expression by shRNA on the apoptosis and proliferation of human colorectal cancer cell
YAO Kun-hou;WEI Lun-shou;MA Wan-li;HU Jun-hong;Department of General Surgery;Huaihe Hospital;Henan University;Department of Gastroenterology;Huaihe Hospital;Henan University;

..............page:2125-2127

Expression of microRNA-18 and estrogen receptor alpha in myomectomy tissue
LIAO Zhi;XIAO Hong-tao;Department of Gynecology and Obstetrics;Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People’ s Hospital;Department of Pharmacy;Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People’ s Hospital;

..............page:2128-2130

Similarity analysis of Sinisan lyophilized power in serum by HPLC fingerprint
LI Yue-feng;CAO Rui;XU Fu-ju;ZHANG Ze-guo;NIU Jiang-tao;YAN Xing-ke;Processing Department of Traditional Chinese Medicine;Pharmacy Institute of University of Traditional Chinese Medicine of Gansu;

..............page:2131-2133

Simultaneous determination of rifampicin, rifapentine and rifabutine in child plasma by UPLC-MS/MS
AN Jing;LIU Hong-tao;DONG Zhan-jun;ZHANG Xiao-dan;Department of Pharmacy;Hebei General Hospital;Department of Pharmacy;Hebei Chest Hospital;

..............page:2134-2136

Determination of lamotrigine in human plasma by liquid chromatography and mass spectrometry
ZHU Yi-fang;HUA Wen-yan;ZHANG Quan-ying;Institute of Clinical Pharmacy;The Second Affiliated Hospital of Soochow University;

..............page:2137-2139

Determination of clozapine and amisulpride in human plasma by high performance liquid chromatography
CHEN Ying;QU Fa-lin;LI Yan;LIN Zhi;CEHN Fang-bin;LI Ning;The 102ndHospital of People’ s Liberation Army;Nanjing University of Chinese Medicine Hanlin College;

..............page:2140-2142

Determination of nilotinib in human plasma by UPLC-MS/MS
PU You-bin;DONG Ji;MIAO Li-yan;Department of Pharmacy The First Affiliated Hospital of Soochow University;

..............page:2143-2145

Determination of six aconitum alkaloid in traditional Mongolian medicine Menggenwusen-Wurile by HPLC
BA Tu-Deligen;BU Ren-batu;HAN Zhi-qiang;Institute of Clinical Pharmacology of Traditional Mongolian Medicine;Affiliated Hospital of Inner Mongolia University for the Nationalities;

..............page:2146-2149

Systematic review of dexmedetomidine hydrochloride assisted anesthesia
XIE Xing-xing;FAN Ling;DU Biao;School of Pharmacy;Sichuan Medical University;Department of Pharmacy;Chongqing Three Gorges Central Hospital;

..............page:2150-2152

Bibliometric analysis of bridging study of new drugs
WANG Kai;LIANG Bei-bei;BAI Nan;MEI He-kun;XU Ying;WANG Jin;WANG Rui;Center of Medicine Clinical Research;Center for Translational Medicine;Chinese People’ s Liberation Army General Hospital;School of Pharmacy;Tianjin Medical University;

..............page:2153-2155

Pharmaceutical care for patient with subacute granulomatous thyroiditis complicated with hepatic dysfunction and hypertension
WANG Yan;JI Huai-xue;REN Ling;Department of Pharmacy;The Affiliated Hospital of Xuzhou Medical College;Department of Pharmacy;the Children Hospital of Xuzhou;

..............page:2156-2157

Clinical application analysis of unstable angina medications
ZHANG Xiu-qin;HUANG Hong-lin;BI Jin-lian;Institute of Pharmacy and Pharmacology;Unversity of South China;Department of Pharmacy;First Affiliated Hospital of University of South China;

..............page:2158-2160

Progress in search for relationship between Irisin and type 2 diabetes mellitus
MA Xiao-mei;Department of Endocrinology;Affilidted Hospital of Qinghai University;

..............page:2161-2163

Advanced development of target molecule affinity coupled with mass spectrometry for the screening of bioactive compounds in traditional Chinese medicines
LI De-qiang;XIAO Yuan-yuan;DAI Rong-yuan;ZHANG Zhi-qing;SHAN Ai-lian;Department of Pharmacy;the Second Hospital of Hebei Medical University;Department of Traumatology;Dacheng County Hospital;The Chinese Journal of Clinical Pharmacology;

..............page:2164-2169

Main consiration of investigational new drug clinical evaluaion
QIAN Si-yuan;WANG Tao;Center for Drug Evaluation;China Food and Drug Administration;

..............page:2170-2174

bei jing da xue lin chuang yao li yan jiu suo jian jie

..............page:2174

General considerations on clinical safety review of a new drug application
HUA Wei-li;WANG Tao;Center for Drug Evaluation;Chinese Food and Drug Administration;

..............page:2175-2178